Prognostic Stage IIB Breast Cancer AJCC v8
66
6
23
27
Key Insights
Highlights
Success Rate
68% trial completion
Published Results
11 trials with published results (17%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
19.7%
13 terminated out of 66 trials
67.5%
-19.0% vs benchmark
2%
1 trials in Phase 3/4
41%
11 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (66)
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study